Trial · NCT06767358
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 19 of 19
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Feasibility: Recruitment Rate | 3 months | Feasibility will be judged by the 3 outcomes of recruitment rate, consent rate, and protocol adherence. We define a successful recruitment rate of 0.5 patients per centre per month over the duration of the trial. |
| Primary | Feasibility: Consent Rate | 3 months | This will be judged by the 3 outcomes of recruitment rate, consent rate, and protocol adherence. We will define \>75% consent rate as successful. |
| Primary | Feasibility: Protocol Adherence | 3 months | This will be judged by the 3 outcomes of recruitment rate, consent rate, and protocol adherence. We will define ≥75% protocol adherence as successful. |
| Secondary | Ventilator-free Days at 28 days | 28 Days | |
| Secondary | 28-day mortality | 28 Days | |
| Secondary | ICU Mortality | 3 months | |
| Secondary | ICU Length of Stay | 3 months | |
| Secondary | Number of Participants receiving a Tracheostomy | 3 months | |
| Secondary | Hospital Mortality | 3 months | |
| Secondary | Hospital Length of Stay | 3 months | |
| Secondary | Delirium | 28 Days | Delirium will be reported using the validated Confusion Assessment Method for the ICU (CAM-ICU) score (dichotomous score) or the Intensive Care Delirium Screening Checlist (ICDSC). Minimum Value: No Delirium Maximum Value: Delirium |
| Secondary | Delirium-Free/Coma-Free Days at 14 days | 14 days | |
| Secondary | Use of anti-psychotics (total dosage) | 28 Days | |
| Secondary | Use of benzodiazepines (total dosage) | 28 Days | |
| Secondary | Post-traumatic stress disorder symptoms at 3 months post ICU discharge | 3 months | This outcome will use the validated Impact of Event Scale - Revised Minimum Value: 0 Maximum Value: 88 Value ≥ 33 consistent with PTSD |
| Secondary | Total dosage of continuous sedative requirements over ICU stay | 28 Days | This outcome will report the total dosage and weight-based mean dosage of continuous sedatives used in the ICU |
| Secondary | Total dosage of analgesic requirements over ICU stay | 28 Days | This outcome will report the total dosage and weight-based mean dosage of analgesics used in the ICU |
| Secondary | Number of participants with arrhythmias | 28 Days | Inclusive of atrial flutter/fibrillation, ventricular fibrillation, ventricular tachycardia |
| Secondary | Number of times participants have emesis/vomiting | 28 Days | Reported incidents of vomiting. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06767358/registered